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Infection with HIV-1 perturbs homeostasis of human T cell subsets, leading to accelerated immunologic deterioration.
While studying changes in CD4
þ memory and naı ¨ve T cells during HIV-1 infection, we found that a subset of CD4
þ
effector memory T cells that are CCR7
 CD45RO
 CD45RA
þ (referred to as TEMRA cells), was significantly increased in
some HIV-infected individuals. This T cell subset displayed a differentiated phenotype and skewed Th1-type cytokine
production. Despite expressing high levels of CCR5, TEMRA cells were strikingly resistant to infection with CCR5 (R5)–
tropic HIV-1, but remained highly susceptible to CXCR4 (X4)–tropic HIV-1. The resistance of TEMRA cells to R5-tropic
viruses was determined to be post-entry of the virus and prior to early viral reverse transcription, suggesting a block at
the uncoating stage. Remarkably, in a subset of the HIV-infected individuals, the relatively high proportion of TEMRA
cells within effector T cells strongly correlated with higher CD4
þ T cell numbers. These data provide compelling
evidence for selection of an HIV-1–resistant CD4
þ T cell population during the course of HIV-1 infection. Determining
the host factors within TEMRA cells that restrict R5-tropic viruses and endow HIV-1–specific CD4
þ T cells with this ability
may result in novel therapeutic strategies against HIV-1 infection.
Citation: Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, et al. (2007) Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV
infection. PLoS Pathog 3(4): e58. doi:10.1371/journal.ppat.0030058
Introduction
Chronic immune activation and homeostatic disturbance
of T cell subsets that accompany viral replication are
hallmarks of HIV-1 infection [1–4]. The cause and implica-
tions of these profound quantitative and qualitative changes
in CD4
þ memory T cell subsets during HIV-1 infection are
still not well understood [2]. Elucidating the causal relation-
ships between perturbed naı ¨ve and memory T cell compart-
ments during the course of HIV-1 infection could be critical
in understanding its pathogenesis.
Human T cells are categorized as naı ¨ve (TN) and memory
(TM) subsets based on expression of CD45RA and CD45RO
isoforms, respectively [5–8]. It is now known that memory T
cells are comprised of distinct subsets that can be identiﬁed
based on other surface markers and effector functions [9].
Sallusto and colleagues deﬁned two CD4
þ memory T cell
subsets, termed central memory (TCM) and effector memory
(TEM) cells [8]. TEM cells have low expression levels of the
chemokine receptor CCR7 and lymph node homing receptor
CD62L, express receptors for migration to inﬂamed tissues,
and display immediate effector functions [8,10]. In contrast,
TCM cells express high levels of CCR7 and lack potent effector
functions. It has been proposed that TCM cells are responsible
for maintaining long-term memory, and upon re-exposure to
antigens, differentiate into TEM cells with effector functions.
Prior studies indicated that HIV-1 preferentially infects
memory, rather than naı ¨ve CD4
þ T cells [11–16], possibly
because of exclusive expression of the HIV-1 coreceptor
CCR5 on memory T cells. Within the memory population,
TEM cells are enriched for expression of CCR5 relative to
other CD4 memory cells [17,18], suggesting that they may be
primary targets for CCR5-tropic (R5-tropic) viruses that
predominate in most infected persons.
Because chronic HIV-1 infection disrupts the balance
between naı ¨ve and memory T cell subsets [19], we characterized
thedistributionofthese cellsduringHIV-1infection.Wefound
that a small subset of CD4
þ TEM cells, which we called CD4
þ
TEMRA cells, were greatly increased in some HIV-infected
individuals relative to uninfected individuals. Remarkably,
CD4
þ TEMRA cells displayed a speciﬁc post-entry block to R5-
tropic HIV-1, despite expressing high levels of CCR5. Accumu-
lation of this effector memory CD4
þ T cell subset during
chronic HIV infection could have important implications in
understanding intrinsic resistance to the virus and perturba-
tion of T cell compartments in infected individuals.
Results
Human T Cell Subset Distribution during HIV-1 Infection
The dynamics of T cell changes were studied in HIV-
infected and HIV-uninfected individuals by staining their
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clonal antibodies against CD3, CD4, CCR7, and CD45RO cell
surface molecules. In most uninfected individuals, this
analysis divides CD4
þ T cells into three subsets that can be
readily quantiﬁed: naı ¨ve T cells (TN;C D 4 5 R O
 CCR7
þ),
central memory T cells (TCM; CD45RO
þCCR7
þ), and effector
memory T cells (TEM;C C R 7
 ) (Figure 1A, left panel).
However, in HIV-uninfected individuals, a fourth subset
(CD45RO
 /dullCCR7
 ) was also observed (Figure 1A), albeit
with a low frequency (0.5%–3%). This subset was greatly
increased in some of the HIV-infected individuals (Figure 1A,
right panel). Because these cells resembled a previously
deﬁned CD8
þ T cell subset (called CD8
þ TEMRA cells) with
effector functions that expressed CD45RA with effector
functions [20], we tentatively termed them CD4
þ TEMRA cells
(referred to as TEMRA cells hereafter). Conversely, we denoted
the CD45RO
þCD45RA
 CCR7
  effector memory CD4
þ T cell
subset as TEMRO cells. The relationship between TEMRA cells
and HIV-1 infection was studied in 33 HIV-infected and 30
HIV-uninfected individuals (Figure 1B). The proportion of
TEMRO and TEMRA subsets was signiﬁcantly increased in HIV-
infected individuals (Figure 1B). On the other hand, the
proportion of TN cells was signiﬁcantly decreased in HIV-
infected individuals, while the proportion of TCM cells
remained similar in both groups (Figure 1B).
Phenotypic Characterization of CD4
þ TEMRA Cells
The high proportion of TEMRA cells found in HIV-infected
individuals prompted further analysis of this subset. We
hypothesized that TEMRA cells are a subset of effector memory
CD4
þ T cells, analogous to a subset recently described for
CD8
þ T cells with the same surface marker phenotype [20].
The four subsets of CD4
þT cells (TN,T CM,T EMRO, and TEMRA)
obtained from HIV-infected and HIV-uninfected individuals
were analyzed for expression of cell surface molecules known
to be expressed differentially in naı ¨ve, memory, and effector
T cells. All TN cells expressed CD28, CD27, CD7, and CD62L,
with progressively less expression on CD4
þ TCM,T EMRO, and
TEMRA cells (Figure 2). In contrast, expression of CD11b,
CD57, and HLA-DR were increased on TEMRO and TEMRA cells
compared to CD4
þ TN and TCM cells (Figure 2). In contrast to
TCM and TEMRO cells, TEMRA cells also expressed high levels of
CD45RA, similar to TN cells (Figure 2, top panel). This proﬁle
suggested that TEMRA cells are a subset of CD4
þ effector
memory T cells with a peculiar CD45RA
þCD45RO
 /dull
phenotype.
Proliferative Capacity and Apoptosis of Effector Memory T
Cell Subsets
Differentiated effector memory T cells have a reduced
proliferative capacity [8,20]. To assess the relative prolifer-
ative capacity of the different CD4
þT cell subsets, each subset
was puriﬁed from an HIV-uninfected individual according to
CCR7 and CD45RO expression as shown in Figure 1A, and
stimulated with dendritic cells (DCs) pulsed with super-
antigen (staphylococcal enterotoxin B [SEB]). Activated T
cells were counted at day 12 (Figure 3A). DC-mediated
activation caused robust cell division of TN and TCM cells
(Figure 3A), whereas TEMRO cells and TEMRA cells divided
fewer times (Figure 3A).
The reduced proliferative capacity of effector T cells
correlates with a decrease in telomere length and with an
increased propensity to undergo apoptosis [9]. To determine
whether TEMRA cells undergo apoptosis similar to effector T
cells, all T cell subsets were stained with a marker of apoptosis
(Annexin V) before and after cells were stimulated through
the T cell receptor (TCR) by anti-CD3 plus anti-CD28
antibodies for 18 h. A higher proportion of effector T cells
underwent apoptosis compared to TN and TCM cells (Figure
3B). Levels of apoptosis were comparable between TEMRO and
TEMRA cells before and after TCR stimulation (Figure 3B).
Cytokine Profile of Human Effector Memory T Cells
A hallmark of TEM cells is secretion of greater quantities of
cytokines when stimulated through the TCR, as compared to
TN and TCM cells [8,10]. We therefore explored cytokine
proﬁles of TEMRO and TEMRA subsets. As expected, [8,10]
TEMRO cells secreted greater amounts of most cytokines
assayed (IL-4, IL-5, IL-10, TNF-a, and IFN-c) compared to TN
and TCM cells (Figure 3C). TEMRA cells secreted high levels of
IFN-c, but much lower levels of IL-4, IL-5, or IL-10 compared
to TEMRO cells (Figure 3C). This cytokine proﬁle suggested
that the TEMRA subset is skewed towards a Th1 phenotype.
Recently, a cell surface molecule called CRTH2 was shown to
be highly expressed on Th2 but not on Th1 cells [21]. To
conﬁrm Th1 skewing of TEMRA cells, we analyzed the surface
expression of CRTH2. In agreement with the cytokine proﬁle,
signiﬁcantly fewer TEMRA cells expressed CRTH2 compared
to TEMRO or TCM subsets (Figure S1). Taken together, we
conclude that TEMRA cells are differentiated effector memory
T cells that are skewed toward a Th1 phenotype.
HIV-1 Infection of TCR-Stimulated CD4
þ T Cell Subsets
Because TEMRA cells were proportionately increased in
some HIV-infected individuals, we next investigated the
susceptibility of these cells to HIV-1 infection. For these
experiments, TN,T CM,T EMRO, and TEMRA cells puriﬁed from
PBMCs of HIV-infected and HIV-uninfected individuals were
activated through the TCR to render them susceptible to
infection. The activated T cells were then infected with either
R5-tropic replication-competent HIV (R5.HIV), CXCR4 (X4)–
tropic replication-competent HIV (X4.HIV), or replication-
defective viruses that only undergo a single round of
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Author Summary
HIV-1 infection profoundly perturbs the immune system and is
characterized by depletion of CD4
þ T cells and chronic immune
activation, which lead to AIDS. Although HIV-1 targets CD4
þ T cells,
it also requires a second receptor in order to infect the target cells.
The majority of HIV-1 strains that are transmitted use a cell surface
molecule called CCR5, which is expressed on a portion of T cells. In
this manuscript we identify a subset of human CD4
þ T cells, which
we termed TEMRA cells, that express CCR5 but still remain resistant to
infection. We show that HIV-1 infection is blocked in TEMRA cells after
entry of the virus, but before it has a chance to integrate into the
cellular genome. TEMRA cells are present at low frequency in HIV-1
uninfected individuals but greatly increase in some HIV-infected
individuals, which correlates with higher CD4
þT cell numbers. These
findings provide the basis for future studies to understand the role
of TEMRA cells during HIV-1 infection and identify the host factors
that could restrict the virus. This knowledge may be used to endow
susceptible T cells with the ability to resist infection and result in
novel vaccine or therapeutic strategies against HIV-1 infection.Figure 1. Distribution of Human CD4
þ T Cell Subsets in HIV-Infected and HIV-Uninfected Individuals
(A) PBMCs from HIV-uninfected and HIV-infected individuals were stained with purified CCR7 antibody, followed by allophycocyanin-conjugated anti-
mouse IgG. After washing, cells were co-stained with CD4-FITC, CD3-Percp.Cy5.5, and CD45RO-PE. Expression of CCR7 and CD45RO were analyzed after
gating on CD4
þCD3
þT cells. Representative flow cytometry data from over 60 individuals are shown. The abbreviated definition of T cell subsets based
on this staining profile is shown above the flow cytometry plots.
(B) CD4
þ T cell subsets were analyzed in HIV-uninfected and HIV-infected individuals. Between 300,000 and 500,000 events were collected for each
sample, and electronic gates were set on CD4
þCD3
þ T cells. Distribution and median percentages of TN (CD45RO
 CCR7
þ), TCM (CD45RO
þCCR7
þ), TEMRO
(CD45RO
þCCR7
 ), and TEMRA (CD45RO
 CCR7
 ) cells in 33 HIV-infected and 30 HIV-uninfected individuals are shown.
doi:10.1371/journal.ppat.0030058.g001
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T Cell Subset That Is Resistant to R5-Tropic HIVreplication and are pseudotyped with vesicular stomatitis
virus glycoprotein G (VSV-G.HIV). Each virus used here
encoded green ﬂuorescent protein (GFP) that was used to
quantify infection by ﬂow cytometry at speciﬁc time points
after inoculation [22].
Prior to the infectivity assay, we analyzed the expression of
HIV-1 co-receptors CCR5 and CXCR4 on TN,T CM,T EMRO,
and TEMRA cells isolated from an HIV-uninfected individual
(Figure 4A). TEMRA and TEMRO cells expressed the highest
levels of CCR5, while all four subsets expressed high levels of
CXCR4 (Figure 4A). In addition, the median CCR5 expression
was quantitated from 20 HIV-infected individuals, and the
similar subset expression trends were conﬁrmed (Figure S2).
When each T cell subset isolated from an HIV-uninfected
individual was challenged with R5.HIV, CD4 TCM and TEMRO
cells were more susceptible to infection than TN cells (Figure
4B), most likely reﬂecting high CCR5 surface expression levels
on these memory T cells (Figure 4A). In contrast, TEMRA cells
were resistant to a high multiplicity challenge with R5.HIV
(Figure 4B, top panel). This was an unexpected ﬁnding given
the high cell surface CCR5 levels on TEMRA cells (Figure 4A).
At day 12 post-infection, R5.HIV spread through the cultures,
producing more infected TN,T CM,a n dT EMRO cells as
compared to 5 d post-infection. Even at this late time point,
TEMRA cells remained almost completely refractory to
infection (Figure 4B, second panel). In contrast, TEMRA cells
were similarly susceptible to infection with X4.HIV, as well as
other T cell subsets (Figure 4B, third panel). Surprisingly,
TEMRA cells were also 5- to 10-fold less susceptible to VSV-
G.HIV infection than other T cell subsets (Figure 4B, bottom
panel).
We then sought to determine whether over time the TEMRA
subset would progressively become more susceptible to
infection post-activation, or whether these cells were being
killed in culture by rapidly replicating virus. For this
experiment, T cells were infected with R5.HIV or X4.HIV
for 2 d at different multiplicities of infection (MOIs) and then
washed to remove input virus. Infection was quantiﬁed based
on GFP expression at different time points after inoculation
(Figure 5A), and viral replication was assessed by quantifying
HIV p24 protein in culture supernatants. R5.HIV replicated
efﬁciently in TN,T CM, and TEMRO cells, but there was little or
no replication in TEMRA cells (Figure 5B). In contrast, X4.HIV
infected and replicated efﬁciently in all four subsets and
rapidly killed most of the T cells (Figure 5A and 5B, right
panels; unpublished data). Similar results were observed when
primary HIV-1 isolates, utilizing different R5-tropic, X4-
tropic, and R5X4-dual tropic HIV-1 envelopes that also
express nef, were used (Figure 5C). The infectivity of TEMRA
cells activated with SEB-pulsed DCs also remained identical
(unpublished data).
The surface marker CD57 identiﬁes terminally differ-
entiated cells [23], and expansion of CD57
þ cells occurs in
HIV-infected individuals [24]. Because TEMRA cells were
enriched in CD57
þ cells (Figure 2), we asked whether CD57
þ
T cells were differentially susceptible to R5-tropic or X4-
tropic viruses. For this experiment, TEMRA and TEMRO cells
were further subdivided into CD57
þ and CD57
  subsets by
ﬂow cytometry cell sorting. Both CD57
þand CD57
 subsets of
TEMRA cells were resistant to infection by R5-tropic virus,
whereas both CD57
þ and CD57
  subsets of TEMRO cells
remained susceptible to R5-tropic virus infection (Figure 6,
top panel). However, the CD57
þ and CD57
  subsets of both
TEMRO and TEMRA cells were similarly susceptible to X4-tropic
viruses (Figure 6, bottom panel). Thus, the relative resistance
of TEMRA cells to R5-tropic HIV was not attributable to
enrichment with the CD57
þ subset.
We next investigated where in the HIV-1 life cycle R5-
tropic infection of TEMRA cells was blocked. Because large
numbers of cells were required for these experiments, we
expanded TN,T CM,T EMRO, and TEMRA cells puriﬁed from
PBMCs of HIV-uninfected individuals using SEB-pulsed DCs
for 12 d in IL-2–containing medium. In order to verify that
CCR5 expression levels were maintained on expanded T cell
subsets and that TEMRA cells remained resistant to R5-tropic
infection, CCR5 expression was determined post-activation
and expansion (Figure 7A, top panel). The expanded subsets
Figure 2. Phenotype of Distinct CD4
þ Human T Cell Subsets
Purified CD4
þT cells were stained with CD45RO and CCR7 in conjunction
with the antibodies shown. Electronic gates were set on TN,T CM,T EMRO,
and TEMRA cells as described in Figure 1A, and expression of various T cell
surface markers was analyzed. A representative profile from an HIV-
infected individual is shown. Similar phenotype was observed in all four
subsets of T cells from six HIV-infected and HIV-uninfected individuals.
doi:10.1371/journal.ppat.0030058.g002
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T Cell Subset That Is Resistant to R5-Tropic HIVwere then reactivated with SEB-pulsed DCs and subsequently
infected with R5.HIV. Although the TEMRA cells maintained
very high CCR5 expression, they remained resistant to R5-
tropic infection (Figure 7A, bottom panel).
We ﬁrst asked whether the block of R5-tropic infection was
at the level of fusion. For this experiment, we employed a
recently developed reporter assay to quantify HIV particle
entry [25]. Expanded TCM,T EMRO, and TEMRA cells were
infected with either R5.HIV, X4.HIV, or VSV-G.HIV. Fusion
of these three viruses with TEMRA cells was similarly efﬁcient,
whereas fusion was inhibited in both TN and Jurkat cells,
which do not express CCR5, or when cells were pre-treated
with T20, a fusion inhibitor (Figure 7B). Collectively, these
data indicate that the R5.HIV infection block in TEMRA cells is
post-fusion.
We next conducted analysis of the stage in the HIV-1 life
cycle at which R5-tropic and VSV-G pseudotyped virus
replication was blocked in the TEMRA subset. Late reverse
transcripts in cells infected with VSV-G.HIV, R5.HIV, and
X4.HIV were analyzed. Infection was blocked at the level of
reverse transcription in TEMRA cells infected with R5.HIV and
VSV-G.HIV, suggesting an early block to infection in these
cells that did not affect X4.HIV (Figure 7C).
Because we did not see the accumulation of late reverse
transcription products, we wanted to understand whether
earlier steps in reverse transcription were impaired. There-
fore, we investigated the initiation of reverse transcription of
R5-tropic and VSV-G pseudotyped virus in TEMRA cells. Early
reverse transcription was assessed by the presence of strong-
stop, minus-strand viral DNA (R/U5 DNA) by quantitative
real-time PCR. Early transcripts were not formed in TEMRA
cells infected with R5.HIV or VSV-G.HIV (Figure 7D). These
data suggest that the block in the HIV-1 life cycle occurs at or
prior to the initiation of reverse transcription.
Correlation of TEMRA Cell Levels with CD4
þCell Numbers in
HIV-Infected Individuals
Our ﬁndings that TEMRA cells are expanded in a portion of
HIV-infected individuals and are highly resistant to R5-tropic
infection prompted us to examine relationships between high
TEMRA cells and CD4 numbers. Among HIV-infected individ-
uals, the TN cell percentage correlated positively with
absolute CD4
þ T cell numbers (Figure 1B). Conversely, the
total TEM cell (TEMRO þ TEMRA) percentage correlated
negatively with CD4
þ T cell numbers (Figure 1B; unpublished
data). To further delineate the association between TEMRO
and TEMRA cell proportions and CD4 numbers, we subdivided
infected individuals into three groups based on their total
TEM cells (Figure 8). Infected individuals in whom the TEM
percentage of their CD4
þ T cells was similar to healthy
individuals (bottom group) had high CD4
þ cell numbers
(Figure 8; unpublished data). In contrast, the group with a
very high TEM cell percentage had low CD4
þ T cell numbers,
and all of these individuals had high levels of TEMRO cells
( F i g u r e8 ,t o pg r o u p ) .I m p o r t a n t l y ,h o w e v e r ,w h e nw e
subdivided the infected individuals with median levels of
TEM cells (Figure 8, middle group), a highly signiﬁcant
association between higher TEMRA cell percentage and higher
CD4
þ T cell numbers and higher TN cells was established
(Figure 8). These results imply that a greater proportion of
TEMRA cells within the effector T cell subset may identify
individuals with better preservation of CD4
þ cell numbers,
and possibly slow HIV-1 disease progression.
Discussion
Our investigation of memory T cell subsets during HIV-1
infection led to the discovery of a unique subset of CD4
þ T
cells called CD4
þ TEMRA cells. We found that these cells are
highly susceptible to infection by X4-tropic HIV-1 but are
almost completely resistant to R5-tropic HIV-1 despite high
levels of cell surface CCR5 expression. These cells are also
relatively resistant to infection by VSV-G pseudotyped HIV-1.
Our ﬁndings are consistent with a recent ex vivo analysis of T
cell subsets from HIV-infected individuals, which demon-
strated that CD4
þCD57
þ effector memory T cells were
associated with approximately ten times fewer copies of viral
DNA than TCM cells [23]. Although both CD57
þ and CD57
 
subsets of TEMRA cells displayed the same R5-tropic HIV-1
infection (Figure 5C), overall, CD57
þ cells are more enriched
within TEMRA cells (Figure 2). Thus, TEMRA cells represent the
ﬁrst unique subpopulation of CD4þ T cells that are uniquely
resistant to HIV-1 infection and may emerge as a conse-
quence selection during infection.
Further studies are required to elucidate how TEMRA cells
can be resistant to R5-tropic infection despite high levels of
CCR5 expression, yet remain susceptible to X4-tropic viruses.
In order to exclude that this restriction was at the level of
post-entry and not because of downregulation or block of
CCR5 by beta-chemokines, we showed that 1) TEMRA cells
permitted entry of R5-tropic HIV-1 as measured by the BlaM-
Vpr virion fusion assay, 2) TEMRA cells continued to express
high levels of CCR5 at the time of infection, 3) and TEMRA
cells were partly less susceptible to VSV-G pseudotyped
viruses that bypass the coreceptor requirement. Taken
together, these results indicate that the post-entry pathway
followed by R5-tropic HIV-1 may differ in TEMRA cells
compared to other CD4
þCCR5
þ T cell subsets and to X4-
tropic HIV-1–infecting TEMRA cells. It is conceivable that
either signaling or the entry pathway through the CXCR4
receptor elicits intracellular events needed for HIV repli-
cation or bypasses mechanisms that otherwise restrict HIV-1
in TEMRA cells.
Elucidating cellular mechanisms that determine why some,
but not all, CCR5-expressing CD4
þ T cells are permissive to
R5-tropic HIV-1 infection could provide clues to identify
Figure 3. Proliferation, Apoptosis, and Cytokine Profile of CD4
þ T Cell Subsets
(A) Sorted CD4
þT cell subsets from an HIV-uninfected individual were activated using DCs pulsed with SEB (10 ng/ml) and expanded in IL-2–containing
medium for 12 d. T cell subsets were then counted to determine fold expansion.
(B) Viability of purified CD4
þ T cell subsets was determined using Annexin V staining after 18 h post-activation. Samples were analyzed by flow
cytometry. Statistical significance was determined using the Student’s two-tailed t test. TN: p ¼ 0.4, TCM: p ¼ 0.002, TEMRO: p ¼ 0.15, and TEMRA: p ¼0.3.
(C) Sorted CD4
þ T cell subsets were activated using plate-bound anti-CD3 (3 lg/ml) and soluble anti-CD28 (1 lg/ml) antibodies. Supernatants were
collected 18–24 h post-activation and analyzed for cytokine production using the cytometric bead assay. The results show the mean of four different
experiments from four different individuals.
doi:10.1371/journal.ppat.0030058.g003
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T Cell Subset That Is Resistant to R5-Tropic HIVFigure 4. Expression of HIV-1 Coreceptors on CD4
þ T Cell Subsets and Their Susceptibility to HIV-1 Infection
(A) CD4
þT cells from an HIV-uninfected individual were stained with CD45RO-PE and CCR7-FITC in conjunction with CCR5 and CXCR4 antibodies. CD4
þ
T cell subsets were gated as described in Figure 1, and expression of CCR5 and CXCR4 was analyzed.
(B) Purified CD4
þT cell subsets from an HIV-uninfected individual were activated using plate-bound anti-CD3 (3 lg/ml) and soluble anti-CD28 (1 lg/ml)
antibodies and concurrently infected with VSV-G.HIV, R5.HIV, or X4.HIV. Percent infected cells was determined by GFP expression of T cells on day 5 and
12 post-infection (p.i.). The results are representative of one of five independent experiments using T cell subsets isolated from five different individuals.
The median infection values at day 5 were: R5-HIV: TN¼1.1, TCM¼9.5, TEMRO¼5.4, and TEMRA¼0.85; X4-HIV: TN¼17, TCM¼36, TEMRO¼43, and TEMRA¼
33; and VSV-G.HIV: TN ¼ 44, TCM ¼ 48, TEMRO ¼ 19, and TEMRA ¼ 6.5.
doi:10.1371/journal.ppat.0030058.g004
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T Cell Subset That Is Resistant to R5-Tropic HIVnatural cellular HIV-1 barriers. Our ﬁndings suggest that at
least one subset of primary human T cells display intrinsic
restriction that limits HIV-1 infection. The presence of
differentiated TEMRA cells in HIV-1 infected individuals and
in uninfected individuals, albeit at lower frequency, suggests
that these cells expand and survive during the course of the
normal immune response. These ﬁndings also pose several
important questions: How do TEMRA cells arise? Are they
repeatedly stimulated memory T cells? What aspect of the
TEMRA cell differentiation program renders them resistant to
HIV-1 infection? For example, TEMRA cells displayed a
preferential Th1 phenotype and exhibited a reduced pro-
liferative capacity as well as a cell surface marker and
cytokine proﬁle characteristic of highly differentiated T cells.
A subset of CD8
þ T cells that are CD45RA
þCD27
  (CD8
þ
TEMRA cells) has been shown to display similar phenotypic
features to CD4
þTEMRA cells characterized here [8,20,26]. It is
not yet clear whether CD4
þ TEMRA cells are functionally
similar to CD8
þ TEMRA cells or what role these subsets play
during chronic viral infections. The homeostatic mechanisms
that induce and maintain CD4
þTEMRA cells also remains to be
determined.
Our ﬁnding that TEMRA cells correlate with higher CD4
þ T
cell numbers in a portion of HIV-infected individuals
suggests that virus infection may positively drive selection
for HIV-resistant cells in vivo, a phenomenon previously
observed only in cell culture but usually involving loss of CD4
expression. Studies using animal models for HIV-1 infection
may aid in determining whether there is a causal relationship
between virus infection and selective enrichment of the
TEMRA subset. Remarkably, HIV-infected individuals whose
TEM cells were composed mostly of TEMRA cells were
signiﬁcantly associated with higher CD4
þ T cell and TN cell
levels. How TEMRA cells accumulate or expand in HIV
patients, and whether they have a protective role against
progression of disease, remains to be determined. Memory
and effector T cells are enriched for CCR5 expression [17,18],
suggesting that they are targets for HIV-1, especially T cells
resident in the gut tissue [27–30]. It is conceivable that after
continuous destruction of susceptible TEMRO cells, an HIV-
resistant subset of TEMRA cells is selected. Alternatively,
TEMRA c e l l sm a yh a v eap r o t e c t i v er o l ea g a i n s tH I V - 1
infection, perhaps because HIV-speciﬁc T cells are enriched
in this subset. If TEMRA cells contain a high proportion of
HIV-speciﬁc effector T cells, this would overcome a potential
Achilles’ heel of the immune response during HIV-1
infection; that is, CD4
þ T cells that are activated by HIV-1
antigens themselves become highly susceptible targets for the
virus [31]. Conferring an HIV-resistant ability to HIV-1–
speciﬁc CD4
þ T cells could lead to novel strategies aimed at
potentiating a protective immune response against HIV-1
infection.
During the primary and asymptomatic phases of HIV-1
infection, R5-tropic viruses predominate, whereas X4-tropic
viruses are found in about 50% of infected individuals at late
stages of HIV disease [32–34]. A more rapid decline in total
CD4
þ T cell counts is often associated with a switch from R5-
tropic to X4-tropic HIV or R5/X4 HIV variants [35]. At
present, it is unclear whether the switch to X4-tropic viruses
is a cause or a consequence of the collapse of the immune
system. Because TEMRA cells remain highly susceptible to X4-
tropic viruses, it would be expected that these cells would also
be rapidly depleted when an X4-tropic switch occurs. If
TEMRA cells contain HIV-speciﬁc T cells or play some other
protective role against infection, then elimination of these
cells by X4-tropic viruses would further weaken the immune
response against HIV-1 and facilitate immunological deteri-
oration.
Figure 5. Replication of HIV-1 Strains in CD4
þ T Cell Subsets
Purified CD4
þ T cell subsets were activated through TCR as in Figure 4 and concurrently infected with replication-competent HIV-1.
(A) R5.HIV and X4.HIV infection time course of CD4
þ T cell subsets from HIV-uninfected and HIV-infected individuals.
(B) Supernatants from purified CD4
þ T cell subsets infected with R5.HIV and X4.HIV cultures were collected at different time points and HIV p24 levels
were measured by ELISA. The percentage of infected cells was determined by GFP expression at different time points post-infection by flow cytometry.
The results are representative of one of five independent experiments from different individuals.
(C) Infection of T cell subsets with HIV-1 expressing different primary isolate envelopes. Percent infected T cells was determined by intracellular p24
staining of T cells on day 4, 6, and 8 post-infection. The T cell subsets in this experiment were also infected with VSG-V.HIV, where the percent infected
cells was determined by GFP expression at 4 day post-infection. The VSV-G-HIV infection was 33% for TN, 33% for TCM, and 9% for TEMRA cells.
doi:10.1371/journal.ppat.0030058.g005
Figure 6. Replication of HIV-1 strains in CD57
þ CD4
þ T cell subsets
Effector memory T cell subsets were subdivided into CD57
þ and CD57
 
portions by sorting, then activated and concurrently infected with R5.HIV
or X4.HIV. The percentage of infected cells was determined by GFP
expression at different time points post-infection by flow cytometry. The
results are representative of one of five independent experiments from
different individuals.
doi:10.1371/journal.ppat.0030058.g006
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T Cell Subset That Is Resistant to R5-Tropic HIVIn summary, our results demonstrate that CD4
þTEMRA cells
are present at a higher frequency in HIV-infected than
uninfected individuals and are resistant to R5-tropic HIV
infection, but not to X4-tropic HIV-1 infection. Studies
focused on emergence of these effector memory T cell subsets
will contribute to a better understanding of HIV-1 patho-
genesis and the role of these cells during normal immune
responses. Decoding the precise molecular mechanism of the
intrinsic resistance of TEMRA cells to R5-tropic infection may
have signiﬁcant implications for developing novel ap-
proaches to endow this unique phenotype on HIV-1–
susceptible T cells.
Materials and Methods
Cell isolation and culture. PBMCs were separated from blood of
HIV-uninfected and HIV-infected individuals through Ficoll-Hypa-
que (Pharmacia, http://www.pﬁzer.com). Resting CD4
þ T cells were
puriﬁed as previously described [22] and were at least 99.5% pure as
determined by post-puriﬁcation FACS analysis. To purify naı ¨ve,
central, and effector memory subsets, puriﬁed CD4
þ cells were
stained with CCR7 and CD45RO antibodies, and CD45RO
 CCR7
þ
(TN), CD45RO
þCCR7
þ (TCM), CD45RO
þCCR7
  (TEMRO), and
CD45RO
 CCR7
  (TEMRA) subsets were sorted using the ﬂow cytom-
eter (FACSAria; BD Biosciences, http://www.bdbioscience.com). The
culture medium used in all experiments was RPMI (Cellgro, http://
www.cellgro.com) and prepared as described before [22]. All
cytokines were purchased from R&D Systems (http://www.
rndsystems.com). In some experiments, TEMRO and TEMRA subsets
were further subdivided into CD57
þ and CD57
  subsets by ﬂow
sorting by staining puriﬁed CD4
þ T cells with CCR7, CD45RO, and
CD57 antibodies. Monocyte-derived DCs were generated as previ-
ously described [22]. The superantigen SEB (Sigma, http://www.
sigmaaldrich.com) was used to stimulate resting T cells in the
presence of DCs [36].
Study participants. Uninfected individuals were adults (ages 21–64,
mean age was 32) with no history of HIV infection. Whole blood
samples from adult participants with HIV infection were obtained
during routine primary care visits. Among the HIV-infected
individuals, 76% were Caucasian, 82% were male, the median (range)
age was 41 (28–59) years, and 79% were receiving potent antire-
troviral therapy. Median (IQR) CD4
þ T cell and log10 plasma HIV-1
RNA values were 380 (270–592) cells/mm
3 and 2.7 (2.6–3.8) copies/ml
plasma, respectively, and 50% had fewer than 400 HIV-1 RNA copies/
ml in plasma. There were no selection criteria based on race or sex.
All participants provided written informed consent that was
approved by the Vanderbilt Institutional Review Board.
Virus production and infections. VSV-G pseudotyped replication-
incompetent HIV were generated as previously described [36]. R5-
tropic and X4-tropic replication-competent viruses were prepared
similarly by transfecting 293T cells with HIV that encodes either R5-
tropic (BaL) or X4-tropic (NL4–3) envelope and EGFP (Clontech,
http://www.clontech.com) in place of the nef gene as previously
described [37]. Wild-type virus (NL4–3) with X4-tropic or with R5-
tropic envelope (BaL) and virus (R8) encoding heat stable antigen
(HSA) in place of vpr [38] with intact nef gene were obtained from
Chris Aiken (Vanderbilt University). Additional viruses used in this
study were as follows. NL4–3–based proviral constructs encoding Env
genes from R5-tropic proviral 92MW965.26, NL JRFL, NL YU2, and
dual-tropic NL89.6 were obtained from Paul Bieniasz (Aaron
Diamond AIDS Research Center) and have been previously described
[39]. R5-tropic virus JRCSF and X4-tropic virus R9 were obtained
from Vineet KewalRamani (National Cancer Institute [NCI]). Typi-
cally, viral titers ranged from 1 3 10
6 to 5 3 10
6 IFU/ml for
replication-competent viruses and 10 3 10
6 to 30 3 10
6 IFU/ml for
VSV-G pseudotyped HIV, as titered on CCR5-expressing Hut78 T cell
lines (gift of Vineet KewalRamani, NCI). Viral replication in T cell
cultures was determined by measuring p24 levels within supernatants
by an ELISA.
T cell apoptosis and cytokine assays. To determine apoptosis, T
cells were stimulated with a-CD3 (OKT-3, ATCC)–coated plates in the
presence of soluble a-CD28 (1 lg/ml; Pharmingen, http://www.
bdbiosciences.com) for 18 h. T cell apoptosis was measured by PE-
conjugated Annexin V according to manufacturer’s instructions (BD
Biosciences). Cytokines (IL-2, IL-4, IL-5, IL-10, TNF-a, IFN- c) in the
supernatants were assayed using a commercially available cytometric
bead assay (CBA) (BD Biosciences) [40], and analyzed using CBA 6-
bead analysis software (BD Biosciences).
FACS analysis. T cells were stained with the relevant antibody on
ice for 30 min (chemokine receptor staining performed at room
temperature for 20 min) in PBS buffer containing 2% FCS and 0.1%
sodium azide. Cells were then washed twice, ﬁxed with 1%
paraformaldehyde, and analyzed with a FACSCalibur or FACSAria
ﬂow cytometer. Live cells were gated based on forward and side
scatter properties, and analysis was performed using FlowJo software
(Tree Star, http://www.treestar.com). The following anti-human anti-
bodies were used for staining: CD3, CD4, CD8, CD45RO, CD45RA,
CD28, CD27, CD11b, CD57, CD7, CD62L, HLA-DR, CCR5 (all from
BD Biosciences), CCR7, and CCR4 (R&D Systems). The CRTH2
antibody used for these experiments has been previously described
[41]. Secondary goat-anti-mouse antibodies were conjugated with
Figure 7. Identifying the Block in R5-Tropic and VSV-G Pseudotyped Infection of TEMRA Cells
Purified CD4
þ T cell subsets were activated using DCs pulsed with SEB (10 ng/ml) and expanded in IL-2–containing medium for 10 d.
(A) Day 12 expanded subsets were stained for CCR5 expression. Cells were then reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV
at an MOI of 5. At day 6 post-infection, cells were then stained for CCR5, and infection was analyzed as determined by GFP expression by flow
cytometry.
(B) R5.HIV, X4.HIV, and VSV-G.HIV carrying a b-lactamase reporter protein were incubated with expanded CD4
þ T cell subsets, TN cells, and Jurkat T cell
line at 37 8C for 2 h to allow virus–cell fusion, CCF2/AM (20 lM) was added, and fluorescence was measured as described in Materials and Methods.
Fluorescence ratios were calculated after subtraction of the average background fluorescence.
(C) Expanded subsets were reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV, X4.HIV, or VSV-G.HIV at an MOI of 5 for 12 h. Cells
were then lysed and processed for real-time PCR analysis using late HIV transcript primers.
(D) Reactivated expanded T cell subsets were lysed and processed for real-time PCR analysis using early HIV transcript primers. All infections were
performed at an MOI of 5. The results are representative of one of five independent experiments using T cell subsets isolated from five different
individuals.
doi:10.1371/journal.ppat.0030058.g007
Figure 8. Association between TEM Subsets and CD4 Numbers in HIV-
Infected Individuals
HIV-infected individuals were separated into three groups based on
percent of their CD4
þ TEM cells. The medium TEM population was
subdivided into TEMRO
highTEMRA
low and TEMRO
lowTEMRA
high,a n dt h e
number of total CD4 cells and TN cells in each group was calculated.
We set the cut-off percentage for defining TEMRO high and low
proportions as 28% of CD4
þ T cells and for TEMRA cells, 8% of CD4
þ T
cells. Statistical analysis was performed with only the medium group
since the bottom group did not contain any TEMRA
high cells (range: 1.6%–
5.5%) and within the top group all individuals contained high TEMRO cells
(range: 31%–59%). Statistical significance between groups was deter-
mined by Wilcoxon rank sum test.
doi:10.1371/journal.ppat.0030058.g008
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T Cell Subset That Is Resistant to R5-Tropic HIVallophycocyanin or PE (BD Biosciences). For the intracellular p24
stain, ﬁxation and permeabilization was performed using a commer-
cial kit (BD Biosciences) according to the manufacturer’s instructions.
Subsequently, cells were stained with anti-p24 for 1 h, followed by
goat-anti-mouse conjugated to allophycocyanin for 30 min.
Virus–cell fusion assay. HIV fusion assays were performed
essentially as previously described [25]. Brieﬂy, viruses carrying a b-
lactamase reporter protein fused to the amino terminus of the virion
protein Vpr (BlaM-Vpr) were added to expanded T cell subsets at 37
8C for 2 h to allow virus–cell fusion. CCF2/AM (20 lM; Aurora
Biosciences Corporation, http://www.vrtx.com) was added, and the
cultures were incubated for 14 h at room temperature. Cells were
pelleted and resuspended in PBS, and the ﬂuorescence was measured
at 447 and 520 nm with a microplate ﬂuorometer after excitation at
409 nm. Uncleaved CCF2 ﬂuoresces green, due to ﬂuorescence
resonance energy transfer between the coumarin and ﬂuorescein
groups; however, cleavage by BlaM results in the dissociation of these
ﬂuorophores, and the emission spectrum shifts to blue. Thus, the
ratio of blue to green cellular ﬂuorescence is proportional to the
overall extent of virus–cell fusion. Fluorescence ratios were calcu-
lated after subtraction of the average background ﬂuorescence of
control cultures containing no virus (blue values) and wells contain-
ing PBS (green values).
Quantitative analysis of HIV reverse transcription in target cells.
Viral DNA was quantiﬁed by real-time PCR using an ABI 7700
instrument (PE Biosystems, http://www.appliedbiosystems.com) with
SYBR Green chemistry. The reaction mixtures (25 ll total volume)
contained 2.5 ll of infected lysate, 12.5 ll of 2x SYBR Green PCR
Master Mix (PE Biosystems), and 50 nM of each primer. A standard
curve was prepared from serial dilutions of HIV plasmid DNA. The
reactions were ampliﬁed and analyzed as previously described [42].
The sequences of primers (R and U5) speciﬁc for early products were
59-GGCTAACTAGGGAACCCACTGCTT (forward) and 59-CTGCTA-
GAGATTTTCCACACTGAC (reverse). The late-product primer se-
quences (R and 5NC) were 59-TGTGTGCCCGTCTGTTGTGT
(forward) and 59-GAGTCCTGCGTCGAGAGAGC (reverse), as pre-
viously described.
Statistical analysis. Statistical analyses were performed using Stata
version 9.0 (http://www.stata.com). T cell subset and clinical data are
presented as means (standard deviation). Statistical signiﬁcance
between groups was determined by Wilcoxon rank sum test. Differ-
ences were considered signiﬁcant at p , 0.05.
Supporting Information
Figure S1. CRTH2 Expression on CD4
þ T Cell Subsets
Puriﬁed CD4
þ T cells were stained with CD45RO and CCR7 in
conjunction with the CRTH2 antibody. Electronic gates were set on
TN,T CM,T EMRO, and TEMRA cells as described in Figure 1, and
expression of CRTH2 was analyzed by ﬂow cytometry. The results
show mean expression from ten different individuals.
Found at doi:10.1371/journal.ppat.0030058.sg001 (146 KB TIF).
Figure S2. CCR5 Expression on CD4
þ T Cell Subsets
PBMCs from HIV-positive individuals were stained with CD4,
CD45RO, CCR7, and CCR5 antibodies. Electronic gates were set on
CD4
þ TN,T CM,T EMRO, and TEMRA cells as described in Figure 1, and
expression of CCR5 was analyzed by ﬂow cytometry. The results show
CCR5 expression from 20 different individuals. The median CCR5
expression levels were: TN¼0.5, TCM¼11.96, TEMRO¼46, and TEMRA
¼ 25.1. Statistical signiﬁcance was determined for TEMRO and TEMRA
versus TCM using the Student’s two-tailed t test. * p , 0.05.
Found at doi:10.1371/journal.ppat.0030058.sg002 (174 KB TIF).
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